Faculty, Staff and Student Publications
An Update On Pathobiologic Roles of Anti-Glycan Antibodies In Guillain-Barré Syndrome
Publication Date
1-1-2010
Journal
F1000 Biology Reports
Abstract
Anti-glycan antibodies directed against gangliosides are now considered the major immune effectors that induce damage to intact nerve fibers in some variants of the monophasic neuropathic disorders that comprise Guillain-Barré syndrome. Recent experimental studies elucidating the complexity of anti-glycan antibody-mediated pathobiologic effects on intact and injured nerves undergoing repair are discussed.
DOI
10.3410/B2-21
PMID
20948812
PMCID
PMC2948347
PubMedCentral® Posted Date
March 2010
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
